Bloomberg the Company

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Follow Us

Industry Products

  • Exchange: OTC US
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Sino Biopharmaceutical Ltd

+ Add to Watchlist

SBMFF:US

0.8800 USD 0.0330 3.61%

As of 20:10:02 ET on 01/06/2015.

Snapshot for Sino Biopharmaceutical Ltd (SBMFF)

Open: 0.8800 Day's Range: 0.8800 - 0.8800 Volume: 228,000
Previous Close: 0.9130 52wk Range: 0.8000 - 1.0380 1-Yr Rtn: -

Stock Chart for SBMFF

No chart data available.
  • SBMFF:US 0.8800
  • 1D
  • 1M
  • 1Y
0.9130
Interactive SBMFF Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for SBMFF

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) 25.2684
Relative P/E vs. SPX -
Earnings Per Share (HKD) (ttm) -
Est. EPS (HKD) (12/2014) 0.2700
Est. PEG Ratio 0.9719
Market Cap (M USD) 4,348.49
Shares Outstanding (M) 4,941.46
30 Day Average Volume 26,224
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield 0.86%
Cash Dividend (HKD) 0.0150
Dividend Ex-Date 12/02/2014
5 Year Dividend Growth -
Next Earnings Announcement 03/26/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for SBMFF

  • Revenue
  • Net Income (M/HKD)
  • Profit Margin (%)

Company Profile & Key Executives for SBMFF

Sino Biopharmaceutical Limited, through its subsidiaries, researches, develops, produces, and sells biopharmaceutical products for the medical treatment of ophthalmia, as well as modernized Chinese medicine and chemical medicine for the treatment of hepatitis.

Tse PingChairman/FounderZhang BaowenVice Chairman/Exec VP
Xu XiaoyangPresident/CEOYe Wei NongAsst President/Gen Mgr:R & D
More Company Profile & Key Executives for SBMFF

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil